Unsere Champions, a successful operator of day nurseries and kindergartens in southern Germany, acquired, for the first time, various childcare facilities in the German-speaking part of Switzerland from private sellers. Vischer advised Unsere Champions on
Grünenthal announced the acquisition of Mestex through the purchase of all of its shares and outstanding options. Mestex is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the
MLL advised and represented an internationally renowned Swiss private bank successfully in an employment dispute concerning a claimed bonus. The dispute concerned a bonus claim raised by a former high ranking employee of the private
PostFinance acquires the e-invoicing business from SIX Paynet, one of Switzerland’s leading e-invoicing providers. The purchase was structured as a bulk asset transfer under the Merger Act and completed on 1 April 2021. It includes the
CeQur, a Swiss medical device company, announced the close of an oversubscribed $115 million equity financing. The company will use the funds to advance commercial plans for CeQur Simplicity, including market development activities, a phased commercial
Nater Dallafior has successfully represented a financial service provider with domicile in Liechtenstein and its directors and employees in three leading cases in international administrative assistance proceedings against the Swiss Federal Tax Administration (“FTA”). The
Consortium of buyers led by Helvetica Capital AG and Bruno Fankhauser acquires Leoni Studer AG from Leoni AG. The transaction has been completed on 30 March 2021 and forms part of Leoni AG’s wider effort to
Peloton Interactive, the largest interactive fitness platform in the world with more than 4.4 m members, closed the acquisition of the Precor business from Amer Sports. Precor is one of the largest global commercial fitness equipment
VectivBio Holding AG announced its initial public offering and listing of its shares on Nasdaq (ticker symbol VECT). VectivBio is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments
Nice & Green, an independent Switzerland-based provider of innovative alternative financing solutions for small and mid-sized listed companies, announced a minority growth investment by Artemis Group, owned by Swiss entrepreneur Michael Pieper. The capital raised
